SUPPLEMENTAL INFORMATION

Methods
Animals
Xenograft models were performed similar to previously reported studies. 1, 2 In brief, Nu/nu immune-compromised female ovariectomized mice (29-32 days old) were obtained from Charles River Laboratories (Wilmington, MA). The animals were allowed a period of adaptation in a sterile and pathogen-free environment ad libitum. Placebo or estradiol pellets (0.72 mg, 60-day release; Innovative Research of America, Sarasota, FL) were implanted s.c.
in the lateral area of the neck in the middle point between the ear and shoulder using a precision trochar (10 gauge) 10 mice each. MCF-7 or MCF-7TN-R cells in the exponential phase of growth were harvested using PBS/EDTA solution and washed. Viable cells (5 x 10 6 ) in a 50 μL sterile PBS suspension were mixed with 100 μL Matrigel Reduced Factors (BD Biosciences, Bedford, MA). Cells were injected in the mammary fat pad through a 5 mm incision in the hypogastric region, and the incision was closed using staples. To minimize differences in tumor matrix between xenographs the same immunocompromised mouse subtype, identical cell-number, similar hormone environments, and equal amounts of Matrigel were used in each xenograft experiment. 3, 4 All the procedures in animals were performed under anesthesia using a mix of isofluorane and oxygen delivered by mask.
Tumor size was measured every 2 days using a digital caliper. The volume of the tumor was calculated using the following formula: 4/3π LS 2 (L = larger radius; S = shorter radius). At necropsy on day 21, animals were euthanized by cervical dislocation after exposure to a CO 2 chamber. Tumors, uteri, livers, and lungs were removed and either frozen in liquid nitrogen or fixed in 10% formalin for further analysis. All procedures involving these animals were 
Western Blot Analysis
Protein analysis was performed as described. 5, 6 Briefly, Cells were plated at 50-60% 
p65 NF-κB -Luciferase assay
As previously described, the cells were seeded in 24-well plates at a density of 5x10 5 cells/well in the same media and allowed to attach overnight. 7, 8 After 18 h, cells were transfected for 5 h in serum-free DMEM with 10 ng of pFC-NF-kB-luciferase plasmid, using 6 μl of Effectene (Qiagen) per μg of DNA, using 6 μl of Effectene (Qiagen) per μg of DNA.
After 5 h the transfection medium was removed and replaced with phenol red-free DMEM supplemented with 5% CS-FBS containing vehicle or indicated concentration of TNF and incubated at 37 °C. After 18 h the medium was removed, and 100 μl of lysis buffer was added per well and then incubated for 15 min at room temperature. Cell debris was pelleted by centrifugation at 15,000 x g for 5 min. Cell extracts were normalized for protein concentration using reagent according to the manufacturers protocol (BioRad Lab.).
Luciferase activity for the cell extracts was determined using luciferase substrate (Promega Corp., Madison, WI) in an Autoluminat Plus luminometer (Berthhold Technologies, Bad
Wildbad, Germany).
Immunofluorescence analysis of EMT markers and morphology
Immunofluorescence was performed as previously described. 9 Briefly, the expression levels of an epithelial cell marker (E-cadherin) and a mesenchymal cell marker (vimentin)
were assessed by indirect immunofluorescence using specific antibodies (Ecadherin: CS- 
